CURRENT ISSUE Current Issue Cover
VOL 8 • NO 4 MAY/JUNE 2017
IN THIS ISSUE

The System Is All Holes and No Cheese

Krista Ramirez, PharmD, BCPS, and Christopher Campen, PharmD, BCOP


The Relationship Between Zinc and Quality of Life in Patients With Upper GI Cancer on Chemotherapy

Edith A. Brutcher,(1) RN, APRN-BC, AOCNP®, Zhengjia Chen,(2) PhD, Anqi Pan,(2) MSPH Candidate, and Tiffany Barrett,(1) MS, RD, CSO, LD


 
Section Seperator

TODAY'S NEWS

ASCO and Other Oncology, Medical Societi...

On May 23, President Trump presented the White Hou...

FDA Grants Priority Review to sBLA for P...

The U.S. Food and Drug Administration (FDA) has ac...

Effect of Fixed Second Appointments on B...

In a UK study reported in The Lancet Oncology, All...

Complications From Thyroid Cancer Surger...

As thyroid cancer rates rise, more patients are ha...

AKT Inhibitor Activity in AKT1-Mutant So...

As reported by Hyman et al in the Journal of Clini...

More News From Today More News
Section Seperator

EDITORIALS & COMMENTARY

A Case-Based Approach for Multiple Myeloma

The clinical and scientific advances relative to multiple myeloma (MM) in the past decade have been staggering...

Palliative Chemo: Does It Only Provide False Hope?

A 48-year-old female with recent diagnosis of adenocarcinoma of unknown origin and metastatic disease to the peritoneum...

Bevacizumab in Serous Ovarian, Peritoneal Cancers

Despite the designation as an uncommon disease, rare cancers exert a significant burden...

Atypical Femoral Fractures: Implications for the AP

Advanced practitioners in oncology (APs) frequently encounter bone-health issues in oncology...

Ixazomib: An Oral Proteasome Inhibitor for MM

Multiple myeloma (MM) is a hematologic malignancy characterized by the proliferation of plasma cells that produce monoclonal immunoglobulins, or paraproteins...

More Editorials & Commentary More Tweets
 
Section Seperator

PREVIOUS HIGHLIGHTS

Final Overall Survival Results of EMILIA...

As reported in <em>The Lancet Oncology</e...

FDA Grants Accelerated Approval to Pembr...

On May 23, 2017, the U.S. Food and Drug Administra...

One in Five Cancers Diagnosed in the Uni...

About one in five cancer diagnoses in the United S...

FDA OCE Launches Drug Information Soundc...

The FDA Drug Information Soundcast in Clinical Onc...

Racial Differences in Risk of Interval C...

The risk for interval colorectal cancer&#x2014...

More Highlights More Highlights
 
Section Seperator
Section Seperator
 
 
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here
click me